Large language models may help identify drug safety signals in clinical notes, though their performance remains below thresholds required for clinical decision support. Researchers evaluated three models — GPT-3.5, GPT-4 and GPT-4o — using clinical notes from 100 patients at…

The FDA has approved the first generic versions of Farxiga, a drug used to treat Type 2 diabetes and reduce the risk of hospitalization for heart failure. The generic, dapagliflozin, is indicated to improve glycemic control in adults with Type 2…

A federal judge has declined to block the mailing of mifepristone prescriptions nationwide while directing the FDA to complete its ongoing review of the drug. U.S. District Judge David Joseph denied a request from Louisiana Attorney General Liz Murrill to…

The FDA is seeking broad legislative changes in its fiscal 2027 budget proposal aimed at accelerating drug development, reducing regulatory burden and expanding oversight authority. Key proposals outlined in the budget include:

On April 6, U.S. News & World Report published its latest ranking of the nation’s 141 PharmD programs, based on peer assessments from academics at accredited institutions. The rankings reflect peer evaluations of academic quality on a 1 to 5…

A federal court has struck down a 12-year-old Health Resources and Services Administration policy that restricted how certain 340B hospitals could make initial drug purchases, finding that the agency failed to adequately explain its reasoning when the rule was issued.…

AbbVie and Genentech are the latest drugmakers to sell prescription medications on TrumpRx, CBS News reported April 6. They are the 10th and 11th drugmakers to offer discounted medications on the website.  TrumpRx now lists AbbVie’s best-selling anti-inflammatory drug Humira…

The Drug Enforcement Administration has issued an Immediate Suspension Order to A+ Pharmacy in Chattanooga, Tenn., suspending the retail drugstore’s authority to handle controlled substances. The action follows a joint investigation with the Tennessee Board of Pharmacy that identified violations…

A Los Angeles-based Cedars-Sinai randomized clinical trial found pharmacist-led transitions-of-care interventions did not significantly reduce 30-day hospital or emergency department utilization among older adults, though certain high-risk patients saw benefit. Here are four things to know from the study, published…

Drug shortages remain a thorn in the side of hospital pharmacy leaders nationwide, but one health system has found the right combination of tools to manage them. The American Society of Health-System Pharmacists reported 216 active drug shortages in early 2026,…